Your browser doesn't support javascript.
loading
cost of unsafe injections in Pakistan and challenges for prevention program
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2006; 16 (9): 622-624
Dans Anglais | IMEMR | ID: emr-77524
ABSTRACT
The burden of disease associated with unsafe therapeutic injection practices in Pakistan is very high. The number of injection per person per year has been estimated to be in the range of 8.2 to 13.6, one of the highest in developing world. Extrapolating this number to the whole country would result in 1.5 billion injections per year. Approximately 4% [75 million] of these are administered for immunization while the remainders are used for therapeutic use. Of these, 94.2% are unnecessary. Average price of an injection [not the complete prescription] is Rs. 20.6 [US$ 0.34]. Under conservative estimate, over three billion rupees or 500 million dollars outof- pocket healthcare resources may be wasted each year. Appropriate use of injections would be highly cost effective. According to adjusted analysis, safe and appropriate use of injection in Pakistan would cost US$ 92 million each year with a high proportion that would be injection devices paid through out-of-pocket expenses. Behaviour change for reduction in number of injections require long-term multidimentional efforts. Interventions in the form of phasing out of convention disposable injection equipment and switching to reuse prevention devices for all injections could prevent the common practice of reuse, hence reducing the transmission of infections
Sujets)
Recherche sur Google
Indice: Méditerranée orientale Sujet Principal: Partage de seringue / Analyse coût-bénéfice / Réutilisation de matériel / Transmission de maladie infectieuse / Injections Type d'étude: Évaluation en économique de la santé Limites du sujet: Humains langue: Anglais Texte intégral: J. Coll. Physicians Surg. Pak. Année: 2006

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Recherche sur Google
Indice: Méditerranée orientale Sujet Principal: Partage de seringue / Analyse coût-bénéfice / Réutilisation de matériel / Transmission de maladie infectieuse / Injections Type d'étude: Évaluation en économique de la santé Limites du sujet: Humains langue: Anglais Texte intégral: J. Coll. Physicians Surg. Pak. Année: 2006